Vol 2008, No 93 (2008)

Table of Contents

Cartoons

Patent jpg
Business Review Editor

Research & Development

Acceleron Signs Deals for Bone-Forming Compounds Abstract pdf
Business Review Editor

Features

Amgen Forced to Surrender Japan Abstract pdf
Business Review Editor
Expanding Large Molecule Capabilities: Teva#8217;s Latest Acquisition Abstract pdf
Business Review Editor
The War Dividend Abstract pdf
Business Review Editor
Therapy Focus #8211; Melanoma Vaccines Abstract pdf
Business Review Editor

Licensing

Forest Licenses Novexel’s Novel Broad-Spectrum Beta-Lactamase Inhibitor Abstract pdf
Business Review Editor
Nycomed Finds Commercialisation Partner for Ciclesonide Abstract pdf
Business Review Editor

General

Clinical Development Attrition Rates Abstract
John Janes

Company Profile

Novo Nordisk AS Abstract
Business Review Editor

Business Commentaries

Patent Reform Could Threaten Innovation Abstract html
Fintan Walton

Deal Trackers

Yondelis (Trabectedin) Abstract pdf
Business Review Editor

Mergers & Acquisitions

GE Healthcare Acquires Whatman Abstract pdf
Business Review Editor


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.